GO:0052652 cyclic purine nucleotide metabolic process: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052652 cyclic purine nucleotide metabolic process describes the chemical reactions and pathways involving cyclic purine nucleotides such as cAMP and cGMP, where the phosphate group forms a diester linkage to two positions on the sugar residue and the base is a purine.
• Cyclic purine nucleotide metabolism is central to signal transduction, and its dysregulation is linked to diseases including malaria, cancer, and metabolic disorders.
• Purine nucleotide cyclases in parasites such as Plasmodium are validated drug targets, underscoring the translational importance of this process.
• Cyclic nucleotides can act extracellularly, influencing intercellular communication and immune responses.
• NAD metabolism intersects with cyclic purine nucleotide pathways, affecting cellular redox and signaling dynamics.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of genes controlling cyclic purine nucleotide metabolism.
Description
Cyclic purine nucleotide metabolic process (GO:0052652) encompasses the biochemical reactions and pathways that synthesize, interconvert, and degrade cyclic nucleotides in which the phosphate group is in diester linkage to two positions on the sugar residue and the base is a purine. This includes the canonical second messengers cyclic AMP (cAMP) and cyclic GMP (cGMP), which are derived from ATP and GTP, respectively. The term is a biological process node in the Gene Ontology and is essential for understanding how cells convert extracellular signals into intracellular responses. Researchers study this process because it controls diverse physiological outputs, from hormone secretion to immune cell activation. In pancreatic beta cells, cyclic purine nucleotides modulate insulin release in response to fuel availability. In macrophages, recycling of phagocytosed bacteria fuels immunometabolic responses that depend on nucleotide metabolism. Moreover, extracellular cyclic nucleotides can act as signaling molecules in their own right, influencing neighboring cells. The malaria parasite Plasmodium relies on purine nucleotide cyclases for life-cycle progression, making these enzymes attractive antiparasitic targets. Thus, GO:0052652 bridges fundamental biochemistry, cell signaling, and disease pathogenesis.
cyclic purine nucleotide metabolic process At A Glance
| GO ID | GO:0052652 |
|---|---|
| GO term | cyclic purine nucleotide metabolic process |
| Ontology | biological_process |
| Synonym | cyclic purine nucleotide metabolism |
| Major function | Synthesis, interconversion, and degradation of cyclic purine nucleotides such as cAMP and cGMP |
| Key enzymes | Adenylyl cyclases, guanylyl cyclases, phosphodiesterases |
| Substrates | ATP, GTP |
| Products | cAMP, cGMP, AMP, GMP |
| Related pathways | Signal transduction, hormone secretion, immune regulation |
What Is GO:0052652?
According to the Gene Ontology, GO:0052652 cyclic purine nucleotide metabolic process is defined as the chemical reactions and pathways involving a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue and the base is a purine. In simpler terms, it covers all enzymatic steps that build, modify, or break down cyclic purine nucleotides like cAMP and cGMP, as well as the regulatory pathways that control their levels.
Why Is cyclic purine nucleotide metabolic process Important in Cell Biology?
Cyclic purine nucleotide metabolism is a cornerstone of cellular signaling because it converts environmental cues into rapid, reversible changes in cell behavior. The balance of cAMP and cGMP controls processes as diverse as insulin secretion, immune cell activation, and parasite development. Disruptions in this metabolic process contribute to metabolic disorders, cancer, and infectious diseases, making its components prime targets for therapeutic intervention.
• Regulates hormone secretion, including insulin release from pancreatic beta cells.
• Controls immune cell function and immunometabolic responses in macrophages.
• Essential for the life cycle of malaria parasites, offering drug targets.
• Interconnects with NAD metabolism, influencing cellular redox and signaling.
• Extracellular cyclic nucleotides mediate intercellular communication.
• Dysregulation is implicated in cancer and metabolic diseases.
• Provides biomarkers for cellular signaling states.
• Enables high-throughput screening for modulators of cyclic nucleotide pathways.
• Supports research on thermogenesis and energy balance.
• Facilitates studies of bacterial small-molecule signaling.
What Happens During cyclic purine nucleotide metabolic process?
Synthesis of cyclic purine nucleotides
In simple terms: Cells build cAMP and cGMP from ATP and GTP using specialized enzymes.
The synthesis of cyclic purine nucleotides begins with the conversion of ATP to cAMP by adenylyl cyclases or GTP to cGMP by guanylyl cyclases. These enzymes catalyze the cyclization of the phosphate group, forming the characteristic diester linkage. In malaria parasites, purine nucleotide cyclases are essential for producing cAMP and cGMP that drive stage-specific development.
Degradation by phosphodiesterases
In simple terms: Enzymes called phosphodiesterases break down cAMP and cGMP to stop the signal.
Phosphodiesterases hydrolyze the cyclic phosphate bond, converting cAMP to AMP and cGMP to GMP. This degradation is critical for terminating signaling and maintaining dynamic turnover. The balance between synthesis and degradation determines the steady-state levels of cyclic purine nucleotides.
Extracellular release and signaling
In simple terms: Cyclic nucleotides can exit cells and affect neighboring cells.
Extracellular cyclic nucleotides have been detected in various biological fluids and can act on cell-surface receptors or be taken up by other cells. This extracellular role expands the signaling scope of cyclic purine nucleotide metabolism beyond the cell of origin. Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses, a process that may involve nucleotide release and sensing.
Integration with NAD metabolism
In simple terms: Cyclic nucleotide pathways are connected to NAD metabolism, which affects energy and redox.
NAD metabolism is dynamically linked to purine nucleotide pools, and changes in NAD availability can influence cyclic nucleotide production. This crosstalk is important for cellular responses to stress and metabolic shifts. The interplay between NAD and cyclic purine nucleotides underscores the broader metabolic network.
Key Genes Involved in GO:0052652 cyclic purine nucleotide metabolic process
The following genes and proteins are central to cyclic purine nucleotide metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADCY1 | Adenylyl cyclase isoform that synthesizes cAMP | Neuronal signaling and cAMP regulation |
| ADCY2 | Adenylyl cyclase isoform | cAMP production in various tissues |
| ADCY3 | Adenylyl cyclase isoform | Metabolic and olfactory signaling |
| ADCY5 | Adenylyl cyclase isoform | Insulin secretion and glucose homeostasis |
| ADCY6 | Adenylyl cyclase isoform | Cardiac and smooth muscle function |
| ADCY8 | Adenylyl cyclase isoform | Learning and memory |
| ADCY9 | Adenylyl cyclase isoform | Immune and metabolic regulation |
| GUCY1A1 | Guanylyl cyclase subunit that synthesizes cGMP | Vascular tone and cGMP signaling |
| GUCY1A2 | Guanylyl cyclase subunit | cGMP production in the nervous system |
| GUCY1B1 | Guanylyl cyclase subunit | Nitric oxide signaling |
| PDE1A | Phosphodiesterase that degrades cAMP and cGMP | Regulation of cyclic nucleotide levels |
| PDE2A | Phosphodiesterase | cAMP and cGMP hydrolysis |
| PDE3A | Phosphodiesterase | Cardiac and metabolic signaling |
| PDE4A | Phosphodiesterase | Inflammation and immune responses |
| PDE5A | Phosphodiesterase | cGMP-specific degradation |
| PDE10A | Phosphodiesterase | cAMP and cGMP regulation in the brain |
| PRKACA | cAMP-dependent protein kinase catalytic subunit | Downstream signaling effector |
| PRKACG | cAMP-dependent protein kinase catalytic subunit | Testis-specific signaling |
How Is cyclic purine nucleotide metabolic process Regulated?
Cyclic purine nucleotide metabolic process is regulated at multiple levels. Adenylyl and guanylyl cyclases are controlled by G-protein-coupled receptors and nitric oxide, respectively, while phosphodiesterases provide feedback degradation. NAD metabolism dynamically influences nucleotide pools, affecting cyclic nucleotide synthesis. In immune cells, phagocytosis and metabolic reprogramming modulate cyclic nucleotide levels to shape responses. Hormonal signals, such as those controlling insulin release, also regulate this process.
cyclic purine nucleotide metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADCY5 | Type 2 diabetes and insulin secretion defects | Knockout mouse or pancreatic beta cell line |
| PDE4A | Inflammatory diseases | Knockout macrophages or immune cell lines |
| GUCY1A1 | Cardiovascular disorders | Knock-in mouse models |
| PDE5A | Pulmonary hypertension | Overexpression cell models |
| Plasmodium cyclases | Malaria | Parasite knockout or point mutation |
Malaria
Purine nucleotide cyclases in Plasmodium are essential for parasite development and are being explored as drug targets. Disruption of cyclic purine nucleotide metabolism impairs the parasite life cycle, highlighting its therapeutic potential.
Metabolic disorders
Cyclic purine nucleotides regulate insulin secretion, and their dysregulation contributes to diabetes and metabolic syndrome. NAD metabolism crosstalk further links this process to metabolic homeostasis.
Cancer
Altered cyclic nucleotide signaling affects cell proliferation and survival, with phosphodiesterases and cyclases emerging as cancer targets. Extracellular cyclic nucleotides can influence tumor microenvironment communication.
Immune dysfunction
Macrophages rely on cyclic purine nucleotide metabolism for immunometabolic responses, and its perturbation can lead to immune disorders. Extracellular cyclic nucleotides modulate immune cell activity.
From cyclic purine nucleotide metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ADCY5 loss affect insulin secretion? | ADCY5 knockout pancreatic beta cells |
| How does PDE4A mutation alter immune responses? | PDE4A point-mutation macrophages |
| Can GUCY1A1 knock-in rescue cGMP signaling? | GUCY1A1 knock-in mice |
| What is the effect of PDE5A overexpression? | PDE5A overexpression cell lines |
| Is Plasmodium cyclase essential for survival? | Parasite knockout or point mutation |
| How does NAD metabolism affect cAMP levels? | Knockout of NAD pathway genes |
How to Study the cyclic purine nucleotide metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | cAMP or cGMP concentration | Quantification in cell lysates |
| Mass spectrometry | Cyclic nucleotide levels | Metabolic profiling |
| FRET biosensors | Real-time cAMP/cGMP dynamics | Live-cell imaging |
| Cyclase activity assay | Enzyme kinetics | Drug screening |
| Phosphodiesterase assay | Hydrolysis rate | Inhibitor testing |
| CRISPR library screen | Gene essentiality | Pathway discovery |
| RNA-seq | Gene expression changes | Transcriptomic analysis |
| Proteomics | Protein interactions | Complex identification |
Cyclic nucleotide quantification
Cyclic AMP and GMP levels can be measured using ELISA, mass spectrometry, or biosensors to assess metabolic flux. These methods are applied to cell lysates or extracellular fluids.
Enzyme activity assays
Adenylyl and guanylyl cyclase activities are assayed using radiolabeled substrates or fluorescent probes. Phosphodiesterase activity is measured by monitoring substrate hydrolysis.
Genetic screens
CRISPR library screening can identify genes that regulate cyclic purine nucleotide metabolism under specific conditions. Bioinformatics analysis of transcriptomic data reveals pathway enrichment.
Imaging and biosensors
Genetically encoded FRET biosensors enable real-time imaging of cAMP and cGMP dynamics in living cells. This approach is used to study signaling in immune and metabolic cells.
How CRISPR Can Be Used to Study GO:0052652 cyclic purine nucleotide metabolic process
Knockout
CRISPR knockout of adenylyl cyclases or phosphodiesterases can reveal their roles in cyclic purine nucleotide metabolism and downstream phenotypes. For example, knocking out ADCY5 in beta cells impairs insulin secretion.
Point Mutation
Point mutations can mimic disease-associated variants in genes like PDE4A, allowing study of altered enzymatic activity. This approach helps dissect specific residues critical for catalysis.
Knock-in
Knock-in of tagged or mutant alleles enables tracking of cyclic nucleotide enzymes in vivo. For instance, a GUCY1A1 knock-in can report cGMP dynamics.
Overexpression
Overexpression of cyclases or phosphodiesterases can elevate or reduce cyclic nucleotide levels, respectively, to test sufficiency. This is useful for validating drug targets.
How EDITGENE Supports cyclic purine nucleotide metabolic process Research
Researchers studying cyclic purine nucleotide metabolic process-related genes often need to determine whether a candidate gene is causally involved in signaling, metabolism, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cyclic purine nucleotide metabolic process research.
Frequently Asked Questions About cyclic purine nucleotide metabolic process
What is GO:0052652 cyclic purine nucleotide metabolic process?
It is the biological process comprising the chemical reactions and pathways involving cyclic purine nucleotides such as cAMP and cGMP, where the phosphate group is in diester linkage and the base is a purine.
What genes are involved in cyclic purine nucleotide metabolic process?
Key genes include adenylyl cyclases (ADCY1-9), guanylyl cyclases (GUCY1A1, etc.), and phosphodiesterases (PDE1-11).
How is cyclic purine nucleotide metabolism regulated?
It is regulated by G-protein-coupled receptors, nitric oxide, phosphodiesterases, and crosstalk with NAD metabolism.
What diseases are linked to cyclic purine nucleotide metabolic process?
Malaria, metabolic disorders, cancer, and immune dysfunction have been associated with this pathway.
What are the substrates of cyclic purine nucleotide metabolism?
ATP and GTP are the primary substrates for cAMP and cGMP synthesis, respectively.
How can I study cyclic purine nucleotide metabolism using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of pathway genes.
What methods measure cyclic purine nucleotide levels?
ELISA, mass spectrometry, and FRET biosensors are commonly used.
Why is cyclic purine nucleotide metabolism important for drug discovery?
Its components are validated targets in malaria and metabolic diseases, and modulators can alter signaling.
What is the role of extracellular cyclic nucleotides?
They can act as signaling molecules affecting neighboring cells and immune responses.
How does NAD metabolism interact with cyclic purine nucleotide metabolism?
NAD availability influences nucleotide pools and can affect cyclic nucleotide production.
Conclusion
GO:0052652 cyclic purine nucleotide metabolic process is a fundamental biological process that governs cellular signaling through cAMP and cGMP. Its dysregulation is implicated in a range of diseases, from malaria to metabolic disorders, making it a rich area for research and therapeutic development. Advances in CRISPR technology and analytical methods continue to illuminate the complex regulation of this pathway, offering new opportunities for intervention.
References
- 1. Lesbats J et al.. 2025. Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses.. Nature 640(8058):524-533 PMID: 40011782
- 2. Himms-Hagen J. 1976. Cellular thermogenesis.. Annu Rev Physiol 38:315-51 PMID: 130826
- 3. Opitz CA et al.. 2015. Dynamics of NAD-metabolism: everything but constant.. Biochem Soc Trans 43(6):1127-32 PMID: 26614649
- 5. Malaisse WJ et al.. 1979. Insulin release: the fuel hypothesis.. Metabolism 28(4):373-86 PMID: 36543
- 6. Camilli A et al.. 2006. Bacterial small-molecule signaling pathways.. Science 311(5764):1113-6 PMID: 16497924
- 7. Baker DA et al.. 2004. Purine nucleotide cyclases in the malaria parasite.. Trends Parasitol 20(5):227-32 PMID: 15105023
- 8. Broadus AE et al.. 1971. Extracellular cyclic nucleotides.. Ann N Y Acad Sci 185:50-66 PMID: 4330516
